Fanconi anemia cell lines deficient in αII spectrin express normal levels of αII spectrin mRNA

Biochemical and Biophysical Research Communications

Volumn 307, Issue 3, 2003, Pages 510-515

  Lefferts, Joel A ^a   Lambert, Muriel W ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Alternative mRNA splicing; Fanconi anemia; II Spectrin; II Spectrin mRNA

Indexed keywords

FODRIN; MESSENGER RNA;

ARTICLE; CELL LINE; DNA CROSS LINKING; DNA REPAIR; DNA SPLICING; FANCONI ANEMIA; GENETIC DISORDER; HUMAN; HUMAN CELL; HYPERSENSITIVITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

EID: 0042171508     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01213-0     Document Type: Article

References (35)

1. Beck K.A., Nelson W.J. A spectrin membrane skeleton of the Golgi complex. Biochim. Biophys. Acta. 1404:1998;153-160.
2. De Matteis M.A., Morrow J.S. The role of ankyrin and spectrin in membrane transport and domain formation. Curr. Opin. Cell Biol. 10:1998;542-549.
3. De Matteis M.A., Morrow J.S. Spectrin tethers and mesh in the biosynthetic pathway. J. Cell Sci. 113:2000;2331-2343.
4. McMahon L.W., Walsh C.E., Lambert M.W. Human α spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex. J. Biol. Chem. 274:1999;32904-32908.
5. McMahon L.W., Sangerman J., Goodman S.R., Kumaresan K., Lambert M.W. Human α spectrin II and the FANCA, FANCC, and FANCG proteins bind to DNA containing psoralen interstrand cross-links. Biochemistry. 40:2001;7025-7034.
6. Sridharan D., Brown M., Lambert W.C., McMahon L.W., Lambert M.W. Nonerythorid αII spectin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links. J. Cell Sci. 116:2003;823-835.
7. Glanz A., Fraser F.C. Spectrum of anomalies in Fanconi anaemia. Med. Genet. 19:1982;412-416.
8. Auerbach A.D. Fanconi anemia. Dermatol. Clin. 13:1995;41-49.
9. Auerbach A.D., Buchwald M., Joenje H. Fanconi anemia. Vogelstein B., Kinzler K.W. The Genetic Basis of Human Cancer. 1998;317-332 McGraw-Hill, New York.
10. ′,8- trimethylpsoralen plus light induced DNA damage in normal and Fanconi's anemia cell lines Cancer Res. 48:1988;2015-2020.
11. Lambert M.W., Tsongalis G.J., Lambert W.C., Hang B., Parrish D.D. Defective DNA endonuclease activities in Fanconi's anemia cells, complementation groups A and B. Mutat. Res. 273:1992;57-71.
12. Lambert M.W., Tsongalis G.J., Lambert W.C., Hang B., Parrish D.D. Correction of the DNA repair defect in Fanconi Anemia complementation groups A and D cells. Biochem. Biophys. Res. Commun. 230:1997;587-591.
13. Lambert M.W., Lambert W.C. DNA repair and chromatin structure in genetic diseases. Prog. Nucleic Acid Res. Mol. Biol. 64:1999;257-309.
14. Brois D.W., McMahon L.W., Ramos N.I., Anglin L.M., Walsh C.E., Lambert M.W. A deficiency in a 230. kDa DNA repair protein in Fanconi anemia complementation group A cells is corrected by the FANCA cDNA Carcinogenesis. 20:1999;1845-1853.
15. Kumaresan K., Lambert M.W. Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links. Carcinogenesis. 21:2000;741-751.
16. Moon R.T., McMahon A.P. Generation of diversity in nonerythroid spectrins: multiple polypeptides are predicted by sequence analysis of cDNAs encompassing the coding region of human nonerythroid α-spectrin. J. Biol. Chem. 265:1990;4427-4433.
17. Cianci C.D., Zhang Z., Pradhan D., Morrow J.S. Brain and muscle express a unique alternative transcript of αII spectrin. Biochemistry. 38:1999;15721-15730.
18. Burzio V., Antonelli M., Allende A.C., Allende J.E. Biochemical and cellular characteristics of the four splice variants of protein kinase CK1α from zebrafish (Danio rerio). J. Cell. Biochem. 86:2002;805-814.
19. ′ incisions produced at the site of a psoralen interstrand cross-link Biochemistry. 41:2002;890-896.
20. Winkelmann J.C., Forget B.G. Erythroid and non-erythroid spectrins. Blood. 82:1993;3173-3185.
21. Goodman S.R., Zimmer W.E., Clark M.B., Zagon J.S., Barber J.E., Bloom M.L. Brain spectrin: of mice and men. Brain Res. Bull. 36:1995;593-606.
22. Kupfer G.M., Yamashita T., Naf D., Suliman A., Asano S., D'Andrea A.D. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2. Blood. 90:1997;1047-1054.
23. Hoshino T., Wang J.X., Devetten M.P., Iwata N., Kajigaya S., Wise R.J., Liu J.M., Youssoufian H. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression. Blood. 91:1998;4379-4386.
24. Kruyt F.A.E., Hoshino T., Liu J.M., Joseph P., Jaiswal A.K., Youssoufian H. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood. 92:1998;3050-3056.
25. Hoatlin M.E., Zhi Y., Ball H., Silvey K., Melnick A., Stone S., Arai S., Howe N., Owen G., Zelent A., Licht J.D. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood. 94:1999;3737-3747.
26. Pang Q., Fagerlie S., Christianson T.A., Keeble W., Faulkner G., Diaz J., Rathbun R.K., Bagby G.C. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Mol. Cell. Biol. 20:2000;4724-4735.
27. Pang Q., Keeble W., Christianson T.A., Faulkner G., Bagby G.C. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity. EMBO J. 20:2001;4478-4489.
28. Bagby G.C. Genetic basis of Fanconi anemia. Curr. Opin. Hematol. 10:2003;68-76.
29. Yamashita T., Kupfer G.M., Naf D., Suliman A., Joenje H., Asano S., D'Andrea A.D. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc. Natl. Acad. Sci. USA. 95:1998;13085-13090.
30. Garcia-Higuera I., Kuang Y., Naf D., Wasik J., D'Andrea A.D. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell. Biol. 19:1999;4866-4873.
31. de Winter J.P., van Der Weel L., de Groot J., Stone S., Waisfisz Q., Arwert F., Scheper R.T., Kruyt F.A., Hoatlin M.E., Joenje H. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9:2000;2665-2674.
32. Medhurst A.L., Huber P.A.J., Waisfisz Q., de Winter J.P., Mathew C.G. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet. 10:2001;423-429.
33. Pace P., Johnson M., Tan W.M., Mosedale G., Sng C., Hoatlin M., de Winter J., Joenje H., Gergely F., Patel K.J. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21:2002;3414-3423.
34. Taniguchi T., D'Andrea A.D. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC. Blood. 100:2002;2457-2462.
35. S.M. Gordon, M. Buchwald, The Fanconi anemia protein complex: mapping protein interactions in the yeast two and three-hybrid systems, Blood 120 (2003) 136-141.